MAPS Responds to FDA Advisors and Sets Future Goals

Lucid News On July 16, the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) responded to the FDA Advisory Committee (AdComm) recommendation against approving MDMA-assisted therapy for PTSD and articulated their forward-looking program goals in the webinar “MAPS, MDMA, and Beyond.” MAPS leaders, including Executive Director Kris Lotlikar and directors overseeing communications and post-prohibition strategy, research, and policy […]